D-0362-2022 Class II Terminated
FDA drug recall D-0362-2022 was initiated by Rubicon Research Private Limited on December 31, 2021 and is designated Class II. Reason for recall: Complaint received of foreign matter (metal) embedded in tablet. The recall status is terminated (terminated November 4, 2022). Affected quantity: 3,684 1000-count bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- January 19, 2022
- Initiation Date
- December 31, 2021
- Termination Date
- November 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,684 1000-count bottles
Product Description
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00
Reason for Recall
Complaint received of foreign matter (metal) embedded in tablet.
Distribution Pattern
Product was distributed to one distributor who may have distributed the product further nationwide.
Code Information
Batch # 210211H1, Exp. date FEB 2024